SINOMED is a global company engaged in patient-focused medical innovations for interventional medicine. We offer pioneering solutions for treating coronary, neurovascular and structural heart disease. We strive to combine the ingenuity of people with the power of technology to achieve new victories against cardiovascular disease.
SINOMED was founded in 2007 as a startup company searching for a way to improve the common coronary stent. Today, the company is a publicly traded company on the Shanghai STAR market and one of the leaders in the Chinese coronary stent market. The company’s headquarters is located in Tianjin, China, with a 6,000 m² class 10,000 cleanroom for manufacturing, quality control and development. Since its humble beginnings, SINOMED has worked closely with industry thought-leaders expanding its product offering to include a portfolio of coronary stents and balloons, as well as neurovascular and structural heart disease products.
We are devoted to becoming a global leader in medical devices, focusing on supporting healthcare professionals in their daily efforts to improve the lives of patients. We do this by continuing to evolve our technologies, focusing on quality in everything we do and striving to secure global access to our devices. At SINOMED, we are creating innovations for health.
Through our efforts, we aim to expose more patients to the benefits of our medical innovations; increasing patient longevity and quality of life.
To become one of the global market leaders in providing valued medical devices in the fields in which we are active.